BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25209928)

  • 1. Etanercept in the treatment of SAPHO syndrome.
    Sáez-Martín LC; Gómez-Castro S; Román-Curto C; Palacios-Álvarez I; Fernández-López E
    Int J Dermatol; 2015 Jun; 54(6):e206-8. PubMed ID: 25209928
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review.
    Marí A; Morla A; Melero M; Schiavone R; Rodríguez J
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1990-6. PubMed ID: 25441866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of SAPHO syndrome with leflunomide. Report of two cases.
    Scarpato S; Tirri E
    Clin Exp Rheumatol; 2005; 23(5):731. PubMed ID: 16173265
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab treatment for SAPHO syndrome.
    Arias-Santiago S; Sanchez-Cano D; Callejas-Rubio JL; Fernández-Pugnaire MA; Ortego-Centeno N
    Acta Derm Venereol; 2010 May; 90(3):301-2. PubMed ID: 20526553
    [No Abstract]   [Full Text] [Related]  

  • 5. [The unknown SAPHO].
    Valleala H; Montonen M; Lindqvist C; Kahn MF; Konttinen YT
    Duodecim; 2000; 116(18):1985-9. PubMed ID: 12017613
    [No Abstract]   [Full Text] [Related]  

  • 6. SAPHO syndrome presenting as septic arthritis in the hip.
    O'Connor DA; Ridha H; Roche CJ; O'Sullivan M
    Ir Med J; 2003 Feb; 96(2):41-2. PubMed ID: 12674151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic approach to SAPHO.
    Rothschild B; Schils J; Lavelle H
    Semin Arthritis Rheum; 2000 Apr; 29(5):332-4. PubMed ID: 10805358
    [No Abstract]   [Full Text] [Related]  

  • 8. Sclerosis and swelling of the clavicle in a 44-year old woman.
    Reith JD; Bauer TW; Schils JP
    Clin Orthop Relat Res; 1998 Oct; (355):328-9. PubMed ID: 9917619
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
    Hurtado-Nedelec M; Chollet-Martin S; Nicaise-Roland P; Grootenboer-Mignot S; Ruimy R; Meyer O; Hayem G
    Rheumatology (Oxford); 2008 Aug; 47(8):1160-7. PubMed ID: 18559374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAPHO syndrome associated with acne conglobata successfully treated with etanercept.
    Su YS; Chang CH
    J Formos Med Assoc; 2015 Jun; 114(6):562-4. PubMed ID: 24189486
    [No Abstract]   [Full Text] [Related]  

  • 11. SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept.
    Vilar-Alejo J; Dehesa L; de la Rosa-del Rey P; Novoa-Medina J; Valerón Almazán P; Santana Medina N; Bastida J
    Acta Derm Venereol; 2010 Sep; 90(5):531-2. PubMed ID: 20814638
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome.
    Touma Z; Arayssi T
    J Clin Rheumatol; 2007 Dec; 13(6):338-40. PubMed ID: 18176144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey.
    Witt M; Meier J; Hammitzsch A; Proft F; Schulze-Koops H; Grunke M
    Semin Arthritis Rheum; 2014 Jun; 43(6):745-50. PubMed ID: 24816195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
    Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
    Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact.
    Freira S; Fonseca H; Ferreira PD; Vasconcelos P; Fonseca JE
    J Adolesc Health; 2014 Aug; 55(2):304-6. PubMed ID: 24726464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arthritis and papulo-pustular skin changes].
    Schafroth Török S
    Praxis (Bern 1994); 2006 Jan; 95(4):117-8. PubMed ID: 16485607
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha blockers in SAPHO syndrome.
    Ben Abdelghani K; Dran DG; Gottenberg JE; Morel J; Sibilia J; Combe B
    J Rheumatol; 2010 Aug; 37(8):1699-704. PubMed ID: 20472920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmoplantar eruption.
    Arias-Santiago S; Husein-ElAhmed H; Aneiros-Fernández J; Girón-Prieto MS; Naranjo-Sintes R
    Cleve Clin J Med; 2010 Oct; 77(10):729-31. PubMed ID: 20889810
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of alendronate in the treatment of the SAPHO syndrome.
    Fioravanti A; Cantarini L; Burroni L; Mazzei MA; Volterrani L; Galeazzi M
    J Clin Rheumatol; 2008 Jun; 14(3):183-4. PubMed ID: 18525442
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of SAPHO syndrome with zoledronic acid.
    Kopterides P; Pikazis D; Koufos C
    Arthritis Rheum; 2004 Sep; 50(9):2970-3. PubMed ID: 15457466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.